Virtus LifeSci Biotech Products ETF
0
Funds holding %
of 6,743 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
20% more capital invested
Capital invested by funds: $3.99M [Q2] → $4.8M (+$810K) [Q3]
8% more funds holding
Funds holding: 12 [Q2] → 13 (+1) [Q3]
2.43% more ownership
Funds ownership: 19.42% [Q2] → 21.85% (+2.43%) [Q3]
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Research analyst outlook
We haven’t received any recent analyst ratings for BBP.
Financial journalist opinion
Charts implemented using Lightweight Charts™